Search Results - Timothy M. Chapman

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential

    Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential by Monika Maciuszek, Antonino Cacace, Eoin Brennan, Catherine Godson, Timothy M. Chapman

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery

    Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery by Claire J Ireland, Timothy M. Chapman, Suneeth F. Mathew, Peter Herbison, Mathew Zacharias

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    The significance of haemochromatosis gene mutations in the general population: implications for screening

    The significance of haemochromatosis gene mutations in the general population: implications for screening by Michael J. Burt, Peter M. George, Jeff Upton, Judith A Collett, Chris Frampton, Timothy M. Chapman, T A Walmsley, B. A. Chapman

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis

    Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis by Timothy M. Chapman, Nathalie Bouloc, Roger S. Buxton, Jasveen Chugh, Kathryn Lougheed, Simon A. Osborne, Barbara Saxty, Stephen J. Smerdon, Debra L. Taylor, David Whalley

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Optimization of an Imidazopyridazine Series of Inhibitors of <i>Plasmodium falciparum</i> Calcium-Dependent Protein Kinase 1 (<i>Pf</i>CDPK1)

    Optimization of an Imidazopyridazine Series of Inhibitors of <i>Plasmodium falciparum</i> Calcium-Dependent Protein Kinase 1 (<i>Pf</i>CDPK1) by Timothy M. Chapman, Simon A. Osborne, Claire Wallace, Kristian Birchall, Nathalie Bouloc, Hayley M. Jones, Keith H. Ansell, Debra L. Taylor, Barbara Clough, Judith L. Green, Anthony A. Holder

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)

    Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) by Timothy M. Chapman, Simon A. Osborne, Nathalie Bouloc, Jonathan M. Large, Claire Wallace, Kristian Birchall, Keith H. Ansell, Hayley M. Jones, Debra L. Taylor, Barbara Clough, Judith L. Green, Anthony A. Holder

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development

    Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Paras... by Judith L. Green, Robert W. Moon, David Whalley, Paul W. Bowyer, Claire Wallace, Ankit Rochani, Rishi Kumar Nageshan, Steven Howell, Munira Grainger, Hayley M. Jones, Keith H. Ansell, Timothy M. Chapman, Debra L. Taylor, Simon A. Osborne, David A. Baker, Utpal Tatu, Anthony A. Holder

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: